Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    50%(1 trials)

    Phase Distribution

    Not Applicable
    2
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    N/ANon-phased studies
    2(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(2)

    Detailed Status

    Completed2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A2 (100.0%)

    Trials by Status

    completed2100%

    Recent Activity

    0 active trials
    Showing 2 of 2
    completednot_applicable

    Investigation of Brain Functional MRI as an Early Biomarker of Recovery in Individuals With Spinal Cord Injury

    NCT03854214
    completednot_applicable

    Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis

    NCT01647321

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT03854214Not Applicable

    Investigation of Brain Functional MRI as an Early Biomarker of Recovery in Individuals With Spinal Cord Injury

    Completed
    NCT01647321Not Applicable

    Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    2